Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum]

Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum]

Peng W, Zhang F, Wang Z, et al. Cancer Manag Res. 2020;12:6977—6985. Page 6980, Effectiveness, second paragraph, last sentence, the text “In third-line and above, the DCR was 81.82% vs 76.59% with no significant difference between the two treat...

Full description

Bibliographic Details
Main Authors: Peng W, Zhang F, Wang Z, Li D, He Y, Ning Z, Sheng L, Wang J, Xia X, Yu C, Zhao Y, Liang H, Hu B, Sun C, Wang D, Cheng Y, Pan M, Xia L, Guo X, Zhang Y, Hu Z, Li X, Lu L, Zhang J, Qian H, Xie H, Sun G
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
apatinib
combination therapy
real-world
advanced gastric cancer
Online Access:https://www.dovepress.com/corrigendum-large-scale-multicenter-prospective-study-of-apatinib-in-a-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/corrigendum-large-scale-multicenter-prospective-study-of-apatinib-in-a-peer-reviewed-article-CMAR

Similar Items